Evidence map›Paper›PMID 42701205›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Outcomes reported in interventional studies for mild cognitive impairment: a scoping umbrella review to inform core outcome set development.

Victoria Grace Gabb, Sam Harding, Tomas Lemke, Sophie Alderman, Natalie Woodward, Julie Clayton, Angus McNair, Winsome Barrett-Muir, Alan Richardson, Jemima Dooley and 3 more

Abstract readScoping Review
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Victoria Grace GabbUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-7688-766X
Sam HardingUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-5870-2094
Tomas LemkeUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0009-0003-0436-8937
Sophie AldermanUniversity of Bath, Bath, UK.ORCID https://orcid.org/0000-0002-7931-6862
Natalie WoodwardUniversity of Bristol, Bristol, UK.
Julie ClaytonUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-2808-3552
Angus McNairNIHR Bristol Biomedical Research Centre, Bristol, UK.ORCID https://orcid.org/0000-0002-2601-9258
Winsome Barrett-MuirReMemBr Lived Experience Expert Group, Bristol, UK.
Alan RichardsonReMemBr Lived Experience Expert Group, Bristol, UK.
Jemima DooleyUniversity of Exeter, Exeter, UK.ORCID https://orcid.org/0000-0003-3418-8112
Sarah RuddNorth Bristol NHS Trust, Bristol, UK.ORCID https://orcid.org/0000-0003-0352-665X
Elizabeth CoulthardUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-0017-9595
Nicholas TurnerUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0003-1591-6997

Funding

National Institute for Health Research (NIHR) NIHR204135
6 · The paper itself

Abstract

There is currently no consensus on the most important treatment outcomes in patients with mild cognitive impairment (MCI). As part of developing a core outcome set for MCI, we conducted a pragmatic scoping umbrella review to summarize outcomes reported in previous studies. Six electronic databases were searched from inception to August 2023. Systematic and scoping reviews in English with ≥70% of studies describing at least one quantitative outcome of interventions involving adults with MCI were eligible. Verbatim outcomes were extracted from eligible papers within selected reviews. From 170 papers covering 153 studies from 42 reviews, 143 unique outcomes were identified. Global cognition was the only outcome reported by more than 50% of studies. Two-thirds of outcomes were reported by no more than three studies. Heterogeneous outcome reporting limits evidence synthesis and treatment evaluation. A core outcome set for MCI is warranted to standardize outcome reporting and offer stronger evidence for decision-making.

Indexed as

Cognitive DysfunctionOutcome Assessment, Health CareHumansScoping Reviews as TopicSystematic Reviews as TopicTreatment OutcomeAlzheimer's diseaseclinical trialscore outcome set (COS)mild cognitive impairment (MCI)outcome selection

Identifiers

PMID42701205
PMCPMC13546403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.